Suppr超能文献

在促性腺激素释放激素拮抗剂方案中使用注射用重组人促卵泡激素α或重组促卵泡素β治疗的患者中卵巢过度刺激综合征的预测

Prediction of Ovarian Hyperstimulation Syndrome in Patients Treated with Corifollitropin alfa or rFSH in a GnRH Antagonist Protocol.

作者信息

Griesinger Georg, Verweij Pierre J M, Gates Davis, Devroey Paul, Gordon Keith, Stegmann Barbara J, Tarlatzis Basil C

机构信息

Department of Reproductive Medicine and Gynecological Endocrinology, University Hospital of Schleswig-Holstein, Campus Luebeck, Luebeck, Germany.

MSD BV, Oss, The Netherlands.

出版信息

PLoS One. 2016 Mar 7;11(3):e0149615. doi: 10.1371/journal.pone.0149615. eCollection 2016.

Abstract

STUDY QUESTION

What is the threshold for the prediction of moderate to severe or severe ovarian hyperstimulation syndrome (OHSS) based on the number of growing follicles ≥ 11 mm and/or estradiol (E2) levels?

SUMMARY ANSWER

The optimal threshold of follicles ≥11 mm on the day of hCG to identify those at risk was 19 for both moderate to severe OHSS and for severe OHSS. Estradiol (E2) levels were less prognostic of OHSS than the number of follicles ≥ 11 mm.

WHAT IS KNOWN ALREADY

In comparison to long gonadotropin-releasing hormone (GnRH) agonist protocols, the risk of severe OHSS is reduced by approximately 50% in a GnRH antagonist protocol for ovarian stimulation prior to in vitro fertilisation (IVF), while the two protocols provide equal chances of pregnancy per initiated cycle. Nevertheless, moderate to severe OHSS may still occur in GnRH antagonist protocols if human chorionic gonadotropin (hCG) is administered to trigger final oocyte maturation, especially in high responder patients. Severe OHSS following hCG trigger may occur with an incidence of 1-2% in a relatively young (aged 18 to 36 years) IVF population treated in a GnRH-antagonist protocol.

STUDY DESIGN, SIZE, DURATION: From the Engage, Ensure and Trust trials, in total, 2,433 women who received hCG for oocyte maturation and for whom the number of follicles ≥ 11 mm and the level of E2 on the day of hCG administration were known were included in the analyses.

PARTICIPANTS/MATERIALS, SETTING, METHODS: The threshold for OHSS prediction of moderate and severe OHSS was assessed in women treated with corifollitropin alfa or daily recombinant follicle stimulation hormone (rFSH) in a gonadotropin-releasing hormone (GnRH)-antagonist protocol. Receiver operating characteristics curve analyses for moderate to severe OHSS and severe OHSS were performed on the combined dataset and the sensitivity and specificity for the optimal threshold of number of follicles ≥ 11 mm, E2 levels on the day of (hCG), and a combination of both, were determined.

MAIN RESULTS AND THE ROLE OF CHANCE

The optimal threshold of follicles ≥ 11 mm on the day of hCG to identify those at risk of moderate to severe OHSS was 19 (sensitivity and specificity 62.3% and 75.6%, respectively) and for severe OHSS was also 19 (sensitivity and specificity 74.3% and 75.3%, respectively). The positive and negative predictive values were 6.9% and 98.6%, respectively, for moderate to severe OHSS, and 4.2% and 99.5% for severe OHSS.

LIMITATIONS, REASONS FOR CAUTION: This was a retrospective analysis of combined data from three trials following ovarian stimulation with two different gonadotropins.

WIDER IMPLICATIONS OF THE FINDINGS

For patients with 19 follicles or more ≥11 mm on the day of hCG, measures to prevent the development of OHSS should be considered. Secondary preventive measures include cycle cancellation or coasting, use of a GnRH agonist to trigger final oocyte maturation in place of hCG and a freeze all strategy.

TRIAL REGISTRATION

ClinicalTrials.gov NCT00702845 NCT00696800 NCT00696878.

摘要

研究问题

基于直径≥11mm的生长卵泡数量和/或雌二醇(E2)水平,预测中度至重度或重度卵巢过度刺激综合征(OHSS)的阈值是多少?

总结答案

在注射人绒毛膜促性腺激素(hCG)当天,直径≥11mm卵泡数量的最佳阈值为19,以此来识别有中度至重度OHSS风险以及重度OHSS风险的患者。相比于直径≥11mm的卵泡数量,E2水平对OHSS的预后价值较低。

已知信息

与长效促性腺激素释放激素(GnRH)激动剂方案相比,在体外受精(IVF)前采用GnRH拮抗剂方案进行卵巢刺激时,重度OHSS的风险降低了约50%,而两种方案每个启动周期的妊娠几率相同。然而,如果使用hCG触发最终卵母细胞成熟,尤其是在高反应性患者中,GnRH拮抗剂方案中仍可能发生中度至重度OHSS。在采用GnRH拮抗剂方案治疗的相对年轻(18至36岁)的IVF人群中,hCG触发后重度OHSS的发生率可能为1%-2%。

研究设计、规模、持续时间:从Engage、Ensure和Trust试验中,总共纳入了2433名接受hCG进行卵母细胞成熟且已知hCG给药当天直径≥11mm的卵泡数量和E2水平的女性进行分析。

参与者/材料、设置、方法:在采用GnRH拮抗剂方案并用注射用重组促卵泡素α或每日重组促卵泡激素(rFSH)治疗的女性中,评估中度和重度OHSS的OHSS预测阈值。对合并数据集进行中度至重度OHSS和重度OHSS的受试者工作特征曲线分析,并确定直径≥11mm卵泡数量、hCG给药当天E2水平以及两者组合的最佳阈值的敏感性和特异性。

主要结果及机遇的作用

在hCG给药当天,直径≥11mm卵泡数量的最佳阈值为19,用于识别有中度至重度OHSS风险的患者(敏感性和特异性分别为62.3%和75.6%),用于识别有重度OHSS风险的患者时也是19(敏感性和特异性分别为74.3%和75.3%)。中度至重度OHSS的阳性预测值和阴性预测值分别为6.9%和98.6%,重度OHSS的阳性预测值和阴性预测值分别为4.2%和99.5%。

局限性、谨慎原因:这是对三项使用两种不同促性腺激素进行卵巢刺激的试验的合并数据进行的回顾性分析。

研究结果的更广泛意义

对于在hCG给药当天有19个或更多直径≥11mm卵泡的患者,应考虑采取措施预防OHSS的发生。二级预防措施包括取消周期或延缓,使用GnRH激动剂代替hCG触发最终卵母细胞成熟以及全冷冻策略。

试验注册

ClinicalTrials.gov NCT00702845 NCT00696800 NCT00696878

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b64/4780699/eff2ba67dd6f/pone.0149615.g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验